Revisiting of TAMs in tumor immune microenvironment: Insight from NF-?B signaling pathway

被引:25
作者
He, Rui [1 ]
He, Yan [1 ]
Du, Ran [3 ]
Liu, Chenxin [1 ]
Chen, Zeran [1 ]
Zeng, Anqi [2 ]
Song, Linjiang [1 ]
机构
[1] Chengdu Univ Tradit Chinese Med, Sch Med & Life Sci, Chengdu 611137, Sichuan, Peoples R China
[2] Sichuan Acad Chinese Med Sci, Inst Translat Pharmacol & Clin Applicat, Chengdu 610041, Sichuan, Peoples R China
[3] Chengdu Normal Univ, Coll Educ & Psychol, Chengdu 611130, Sichuan, Peoples R China
关键词
Tumor-associated macrophages; NF-& kappa; B; MicroRNAs; Tumor immune microenvironment; KAPPA-B; HEPATOCELLULAR-CARCINOMA; MACROPHAGE POLARIZATION; CELL-PROLIFERATION; INNATE IMMUNITY; UP-REGULATION; STEM-CELLS; CANCER; INFLAMMATION; METASTASIS;
D O I
10.1016/j.biopha.2023.115090
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Tumor-associated macrophages (TAMs) are key components of tumor immune microenvironment and play a dual role in promoting tumor growth and anti-tumor immunity. Therefore, regulating TAMs has become a promising method in cancer immunotherapy. NF- ?B pathway is the key regulatory pathway of TAMs. Targeting this pathway has shown the potential to improve tumor immune microenvironment. At present, there are still some controversies and the idea of combined therapy in this field. This article reviews the progress in the field of immunotherapy in improving tumor immune microenvironment by exploring the mechanism of regulating TAMs (including promoting M1 polarization, inhibiting M2 polarization and regulating TAMs infiltration).
引用
收藏
页数:11
相关论文
共 112 条
[1]   lncRNA DCST1-AS1 Facilitates Oral Squamous Cell Carcinoma by Promoting M2 Macrophage Polarization through Activating NF-κB Signaling [J].
Ai, Yilong ;
Liu, Shiwei ;
Luo, Hailing ;
Wu, Siyuan ;
Wei, Haigang ;
Tang, Zhe ;
Li, Xia ;
Zou, Chen .
JOURNAL OF IMMUNOLOGY RESEARCH, 2021, 2021
[2]   Toll-like receptor signalling [J].
Akira, S ;
Takeda, K .
NATURE REVIEWS IMMUNOLOGY, 2004, 4 (07) :499-511
[3]   Regulation of PD-L1 Expression by NF-κB in Cancer [J].
Antonangeli, Fabrizio ;
Natalini, Ambra ;
Garassino, Marina Chiara ;
Sica, Antonio ;
Santoni, Angela ;
Di Rosa, Francesca .
FRONTIERS IN IMMUNOLOGY, 2020, 11
[4]   Therapeutic Targeting of the Tumor Microenvironment [J].
Bejarano, Leire ;
Jordao, Marta J. C. ;
Joyce, Johanna A. .
CANCER DISCOVERY, 2021, 11 (04) :933-959
[5]   Understanding the tumor immune microenvironment (TIME) for effective therapy [J].
Binnewies, Mikhail ;
Roberts, Edward W. ;
Kersten, Kelly ;
Chan, Vincent ;
Fearon, Douglas F. ;
Merad, Miriam ;
Coussens, Lisa M. ;
Gabrilovich, Dmitry I. ;
Ostrand-Rosenberg, Suzanne ;
Hedrick, Catherine C. ;
Vonderheide, Robert H. ;
Pittet, Mikael J. ;
Jain, Rakesh K. ;
Zou, Weiping ;
Howcroft, T. Kevin ;
Woodhouse, Elisa C. ;
Weinberg, Robert A. ;
Krummel, Matthew F. .
NATURE MEDICINE, 2018, 24 (05) :541-550
[6]   Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards [J].
Bronte, Vincenzo ;
Brandau, Sven ;
Chen, Shu-Hsia ;
Colombo, Mario P. ;
Frey, Alan B. ;
Greten, Tim F. ;
Mandruzzato, Susanna ;
Murray, Peter J. ;
Ochoa, Augusto ;
Ostrand-Rosenberg, Suzanne ;
Rodriguez, Paulo C. ;
Sica, Antonio ;
Umansky, Viktor ;
Vonderheide, Robert H. ;
Gabrilovich, Dmitry I. .
NATURE COMMUNICATIONS, 2016, 7
[7]   let-7 microRNAs in development, stem cells and cancer [J].
Buessing, Ingo ;
Slack, Frank J. ;
Grosshans, Helge .
TRENDS IN MOLECULAR MEDICINE, 2008, 14 (09) :400-409
[8]   STAT3/NF-κB signalling disruption in M2 tumour-associated macrophages is a major target of PLGA nanocarriers/PD-L1 antibody immunomodulatory therapy in breast cancer [J].
Cavalcante, Romulo S. ;
Ishikawa, Uta ;
Silva, Emanuell S. ;
Silva-Junior, Arnobio A. ;
Araujo, Aurigena A. ;
Cruz, Luis J. ;
Chan, Alan B. ;
de Araujo Junior, Raimundo F. .
BRITISH JOURNAL OF PHARMACOLOGY, 2021, 178 (11) :2284-2304
[9]   Anergic CD8+ T Lymphocytes Have Impaired NF-κB Activation with Defects in p65 Phosphorylation and Acetylation [J].
Clavijo, Paul E. ;
Frauwirth, Kenneth A. .
JOURNAL OF IMMUNOLOGY, 2012, 188 (03) :1213-1221
[10]   Myeloid-Derived Suppressor Cells: Ductile Targets in Disease [J].
Consonni, Francesca Maria ;
Porta, Chiara ;
Marino, Arianna ;
Pandolfo, Chiara ;
Mola, Silvia ;
Bleve, Augusto ;
Sica, Antonio .
FRONTIERS IN IMMUNOLOGY, 2019, 10